Lipoprotein Management in Patients With Cardiometabolic Risk

By J. Brunzell, M. Davidson, C. Furberg, R. Goldberg, B. Howard, J. Stein, J. Witztum. Diabetes Care, 2008

829 citations recorded by the source corpus.

Subfields: Cancer Research, Endocrinology, Diabetes and Metabolism, Surgery

View Paper: https://www.semanticscholar.org/paper/b63962f0c333abde85a20c6f743e73f5272f81ab

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cancer Research

1. Arshag D. Mooradian
2. A. Classification

In Endocrinology, Diabetes and Metabolism

1. Arshag D. Mooradian
2. A. Classification

In Surgery

1. Arshag D. Mooradian
2. A. Classification

Citations in the corpus

• Standards of Medical Care in Diabetes—2009 (2009, background): “In 2008, a consensus panel convened by ADA and the American College of Cardiology recommended a greater focus on non-HDL cholesterol and apolipoprotein B (apo B) in patients who are likely to have small LDL particles, such as people with diabetes (208).”
• Dyslipidemia in type 2 diabetes mellitus (2009, background): “Specialized lipid tests, such as measurement of plasma ApoB-10”